KLF4 responds to both USS and OSS, attenuating atherosclerosis by suppressing TGF-β activity, which is mediated by the MEKK3/MEK5/ERK5/MEF2 cascade activation [22,36]. Here, KLF4 is linked to atherosclerosis.